Literature DB >> 28741692

Inflammatory and endothelial markers during vaso-occlusive crisis and acute chest syndrome in sickle cell disease.

Marein Schimmel1,2, Brenda M Luken2, Erfan Nur1, Charlotte F J van Tuijn1, Joep W Sins1, Dees P M Brandjes3, Sacha S Zeerleder1,2, Bart J Biemond1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28741692     DOI： 10.1002/ajh.24868

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  4 in total

1.  Increased Circulating Copeptin Levels Are Associated with Vaso-Occlusive Crisis and Right Ventricular Dysfunction in Sickle Cell Anemia.

Authors:  Onur Sinan Deveci; Caglar Ozmen; Muhammet Bugra Karaaslan; Aziz Inan Celik; Hatice Rahimova; Anil Akray; Omer Tepe; Emel Gurkan; Ali Deniz
Journal:  Med Princ Pract       Date:  2021-12-01       Impact factor: 1.927

2.  Antibiotics for treating acute chest syndrome in people with sickle cell disease.

Authors:  Arturo J Martí-Carvajal; Lucieni O Conterno; Jennifer M Knight-Madden
Journal:  Cochrane Database Syst Rev       Date:  2019-09-18

3.  Evaluation of Alpha-1 Antitrypsin Levels and SERPINA1 Gene Polymorphisms in Sickle Cell Disease.

Authors:  Magda Oliveira Seixas Carvalho; André Luís Carvalho Santos Souza; Mauricio Batista Carvalho; Ana Paula Almeida Souza Pacheco; Larissa Carneiro Rocha; Valma Maria Lopes do Nascimento; Camylla Vilas Boas Figueiredo; Caroline Conceição Guarda; Rayra Pereira Santiago; Adekunle Adekile; Marilda de Souza Goncalves
Journal:  Front Immunol       Date:  2017-11-06       Impact factor: 7.561

4.  Hydroxyurea treatment is associated with reduced degree of oxidative perturbation in children and adolescents with sickle cell anemia.

Authors:  Caian L Vinhaes; Rozana S Teixeira; Jay A S Monteiro-Júnior; Rafael Tibúrcio; Juan M Cubillos-Angulo; María B Arriaga; Adrielle G Sabarin; Amâncio J de Souza; Jacqueline J Silva; Isa M Lyra; Ana Marice Ladeia; Bruno B Andrade
Journal:  Sci Rep       Date:  2020-11-04       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.